ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 5,550.00
0.00 (0.00%)
At close: Feb 19, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 226 billion as of February 20, 2026. Its market cap has increased by 39.88% in one year.
Market Cap
226.00B
Enterprise Value
223.53B
Revenue
66.39B
Ranking
n/a
PE Ratio
8.71
Stock Price
5,550.00
Market Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 226.00B, an increase of 303.81%. That is a compound annual growth rate of 8.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 226.00B | 9.85% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 320.76B |
| curacle co.,ltd. | 295.56B |
| Genome & Company | 273.91B |
| Prestige Biologics | 221.98B |
| Vaxcell-Bio Therapeutics | 217.69B |
| QuadMedicine | 208.91B |
| Bio Solution | 205.95B |
| Ensol Biosciences | 202.80B |